| Patient | Ulysses S. Grant |
|---|---|
| Date of birth | 1964-04-27 |
| Identifiers | MRN HR-NI002-SYN; SSN (made up) 000-02-9416 |
| Document date | 2026-08-04 |
| Author | Corinne Batiste, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Pre-treatment primary care review after staging. [S]
Mr. Grant returns after staging. The final pathology confirmed p16-negative squamous cell carcinoma of the right tonsillar pillar, and last week's PET/CT showed no distant spread. The head and neck oncology team has recommended chemoradiation, to start in about ten days. The cold he had last week has cleared, apart from a light cough in the mornings. His throat pain is 4 of 10, down from 6 while he was coughing. He weighs 75.5 kg, 2.5 kg below his weight at intake. He saw the dietitian last week and takes soft, calorie-dense foods with two supplement drinks a day. He has smoked no cigars for three weeks and takes varenicline 1 mg twice daily after meals without nausea or changes in mood or sleep. He worries about money and about finishing his memoir during treatment, but still enjoys his writing and his visitors. He has not yet seen a dentist. [S]
| Element | Detail |
|---|---|
| Staging | p16-negative squamous cell carcinoma; PET/CT shows no distant spread |
| Treatment plan | Chemoradiation by the head and neck oncology team, starting in about ten days |
| Pain | 4 of 10, down from 6 during last week's cold |
| Weight and nutrition | 75.5 kg, down 2.5 kg from intake; dietitian seen; two supplement drinks a day |
| Tobacco | No cigars for three weeks; varenicline 1 mg twice daily tolerated |
| Mood | Worried about money and his memoir; still enjoys his writing |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight down 2.5 kg since intake; no fever |
| Ears, nose, mouth, and throat | Positive | Right-sided throat pain, 4 of 10, worse with swallowing; nasal congestion resolved |
| Respiratory | Positive | Light morning cough after last week's cold; no sputum, hemoptysis, or breathlessness |
| Gastrointestinal | Negative | No nausea or vomiting |
| Psychiatric | Positive | Worry about finances and his writing; interest and enjoyment preserved; PHQ-2 score 2 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice daily | One tablet by mouth daily for three days, then twice daily | Oral route | 2026-07-07 to 2026-07-21 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily | One tablet by mouth twice daily after meals | Oral route | 2026-07-21 | active | S |
| Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain | 20 mL by mouth every 6 hours as needed for pain; no more than 3,000 mg a day | Oral route | 2026-07-07 | active | S |
| Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain | Swish 15 mL and spit up to every 3 hours as needed, no more than 8 doses a day; do not eat or drink for 60 minutes after use | Topical route | 2026-07-07 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-04 | Body height | 173 | cm | S |
| 2026-08-04 | Body weight | 75.5 | kg | S |
| 2026-08-04 | Body mass index (BMI) [Ratio] | 25.2 | kg/m2 | S |
| 2026-08-04 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-04 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-08-04 | Heart rate | 74 | /min | S |
| 2026-08-04 | Respiratory rate | 16 | /min | S |
| 2026-08-04 | Body temperature | 36.8 | Cel | S |
| 2026-08-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-04 | Hemoglobin [Mass/volume] in Blood | 13.8 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-08-04 | Leukocytes [#/volume] in Blood by Automated count | 7.9 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-08-04 | Platelets [#/volume] in Blood by Automated count | 255 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-08-04 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-08-04 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-08-04 | Creatinine [Mass/volume] in Serum or Plasma | 0.95 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-08-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 90 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-08-04 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-08-04 | Albumin [Mass/volume] in Serum or Plasma | 3.6 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-08-04 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 2026-08-04 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 2 | {score} | S |
Vital signs recorded on 2026-08-04; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert; lost some weight but well-appearing |
| Oropharynx | Ulcerated lesion of the right tonsillar pillar; biopsy site healed |
| Teeth and gums | Several restored teeth and gum recession; no obvious abscess |
| Neck | Firm right level II node, unchanged; no new nodes |
| Lungs | Clear |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Squamous cell carcinoma of the right tonsillar pillar, p16-negative, suspected at presentation and confirmed by biopsy at the otolaryngology visit; linked to the documented 1885 diagnosis | active | confirmed | C09.1 | S — Synthetic diagnosis in the modern episode; the 1884-1885 findings remain D. |
| Nicotine dependence, cigars, about ten a day for more than forty years | active | confirmed | F17.290 | S — Synthetic modern diagnosis linked to documented heavy cigar smoking. |
| Painful swallowing with oropharyngeal dysphagia from the tonsillar tumor | active | confirmed | R13.12 | S — Synthetic symptom diagnosis echoing the documented painful swallowing. |
| Unintended weight loss from painful swallowing, about 2 kg before presentation | active | confirmed | R63.4 | S — Synthetic finding from the measured weights. |
| Acute viral bronchitis after a head cold during the cancer workup, resolved without antibiotics | resolved | confirmed | J20.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Completed today | Hemoglobin 13.8, white count 7.9, platelets 255, sodium 138, potassium 4.4, creatinine 0.95, eGFR 90, glucose 90, all normal; albumin 3.6, down from 3.9 |
| Laboratory | Final pathology with p16 | At diagnosis | Up to date | Squamous cell carcinoma, p16-negative |
| Imaging | PET/CT for staging | Once carcinoma is confirmed | Up to date | Done last week: no distant spread |
| Laboratory | TSH | Baseline before neck radiation, then every 6 to 12 months after it | Up to date | Baseline 1.8 mIU/L at intake |
| Referral | Multidisciplinary head and neck oncology team | After tissue diagnosis | Up to date | Seen; chemoradiation recommended, starting in about ten days |
| Referral | Dental evaluation before radiation | Before radiation to the neck | Referred | Booked for this week, before radiation planning |
| Referral | Speech-language pathology swallowing baseline | Before treatment | Referred | Referred today for a baseline assessment and preventive swallowing exercises |
| Referral | Dietitian assessment | Before treatment | Up to date | Seen last week; soft, calorie-dense diet with two supplement drinks a day |
| Examination | Weight | Every visit | Completed today | 75.5 kg, 3.2 percent below baseline |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 4 of 10 |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Completed today | Score 2 |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for three weeks; relapse-prevention counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | No nausea, mood, sleep, or behavior change on 1 mg twice daily |
| Medication safety | Pneumococcal vaccination before cancer treatment | Once | Completed today | PCV20 given today |
Goal progress:
Immunizations given today: Pneumococcal conjugate vaccine PCV20 [S]
Guideline basis: NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026)
Follow-up: Chemoradiation with the head and neck oncology team, starting in about ten days; that team follows his weight, pain, and blood counts weekly during treatment. Primary care visit about three weeks after treatment ends. Next scheduled visit 2026-10-22: primary care visit three weeks after completing chemoradiation directed by the head and neck oncology team. [S]